$Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience$

Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience

Introduction: To evaluate the effectiveness and safety of intravitreal dexamethasone (DEX) implants in refractory diabetic macular edema (DME) treated by intravitreal ranibizumab.Materials and Methods: We retrospectively analyzed DME patients who received DEX implant treatment after being refractory...

Full description

Bibliographic Details
Main Authors:	Ning-Yi Hsia, Chun-Ju Lin, Huan-Sheng Chen, Cheng-Hsien Chang, Henry Bair, Chun-Ting Lai, Jane-Ming Lin, Wen-Lu Chen, Peng-Tai Tien, Wen-Chuan Wu, Yi-Yu Tsai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Medicine
Subjects:	diabetic macular edema intravitreal dexamethasone implant intravitreal ranibizumab ozurdex refractory diabetic macular edema
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.649979/full

Similar Items

Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01)

Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
by: Saud M Aljohani, et al.
Published: (2021-01-01)

Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants
by: Yu-Te Huang, et al.
Published: (2022-06-01)

Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
by: Rishi, Pukhraj, et al.
Published: (2020-04-01)

Anterior migration of Ozurdex implant: a review on risk factors, complications, and management
by: Panagiotis Tsoutsanis, et al.
Published: (2023-11-01)

Short-term results of intravitreal dexamethasone implant (OZURDEX®) in treatment of recalcitrant diabetic macular edema: A case series
by: Pukhraj Rishi, et al.
Published: (2012-01-01)

The Efficacy of Single-Dose Intravitreal Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-VEGF Therapy: Real-Life Results
by: Mert Simsek, et al.
Published: (2020-02-01)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review
by: Kishore K, et al.
Published: (2022-04-01)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
by: Joshi L, et al.
Published: (2016-10-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections
by: Yen-Chieh Chang, et al.
Published: (2023-03-01)

Real-world outcomes of two-year Conbercept therapy for diabetic macular edema
by: Yong Cheng, et al.
Published: (2021-03-01)

Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema
by: Taloni A, et al.
Published: (2023-12-01)

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
by: Vadalà M, et al.
Published: (2020-09-01)

Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens
by: Partha Biswas, et al.
Published: (2018-01-01)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
by: Chiung-Yi Chiu, et al.
Published: (2021-01-01)

Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
by: Lokman Balyen, et al.
Published: (2018-01-01)

Intravítrea de bevacizumab vs. bevacizumab y triamcinolona para el edema macular diabético
by: Ileana Vila Dopico, et al.

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
by: Hall J
Published: (2016-08-01)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
by: Xiu-Xian Wang, et al.
Published: (2021-12-01)

Role of Intravitreal Dexamethasone Implant in the Management of Treatment-Naive Diabetic Macular Edema: A Pre-Cataract Surgical Approach for Patients with Systemic Contraindications to Anti-VEGF Therapy
by: Chakraborty S, et al.
Published: (2024-01-01)

Efficacy of intravitreal injection of Conbercept in the treatment of diabetic macular edema
by: Chen Jiang, et al.
Published: (2018-02-01)

Treatment before macular grid in patients of diabetic macular edema
by: P S Srilatha, et al.
Published: (2018-01-01)

An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data
by: Dominic Muston, et al.
Published: (2018-12-01)

Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
by: Rajvardhan Azad, et al.
Published: (2012-01-01)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020-03-01)

Effect of intravitreal injection of Conbercept with laser photocoagulation on diabetic macular edema
by: Qiu-Xia Li, et al.
Published: (2018-06-01)

Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial
by: Alireza Ramezani, et al.
Published: (2024-03-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Intravitreal Dexamethasone Implant for the Treatment of Patient with Resistant to Anti-VEGF Diabetic Macular Edema
by: M. M. Bikbov, et al.
Published: (2020-08-01)

Evaluation of intravitreal corticosteroids as an adjuvant to bevacizumab for diabetic macular edema using electroretinogram
by: Hesham A Enany
Published: (2015-01-01)

Curative effect of Conbercept for different types of macular edema after cataract surgery with diabetes
by: Hua-Bin Zheng, et al.
Published: (2020-11-01)

One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab
by: Mahmoud Alaa Abouhussein, et al.
Published: (2021-01-01)

Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema
by: Jia-Kang Wang, et al.
Published: (2020-11-01)

Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-Life Study
by: Abdullah Ozkaya, et al.
Published: (2017-10-01)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
by: Massin P, et al.
Published: (2016-07-01)

Intravitreal Triamcinolone Acetonide for Patients with Macular Edema due to Branch Retinal Vein Occlusion
by: Kai-Chun Cheng, et al.
Published: (2006-07-01)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex®) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
by: Murat Garlı, et al.
Published: (2021-12-01)

Evaluation of diabetic macular edema by using optical coherence tomography in patients underwent combined phacoemulsification and intravitreal ranibizumab injection versus patients underwent sequential intravitreal ranibizumab injection and phacoemulsification: an observational study
by: Mohamed T El-Behaidy, et al.
Published: (2023-01-01)

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
by: Ume Sughra, et al.
Published: (2021-10-01)